Asston Pharmaceu

{
  "main_header": {
    "sid": 10039662,
    "name": "Asston Pharmaceu",
    "stock_name": "Asston Pharmaceu",
    "full_name": "Asston Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/asston-pharmaceu",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.30",
    "chg": 3.9,
    "chgp": "5.17%",
    "dir": 1,
    "prev_price": "75.40",
    "mcapval": "68.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544445,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0SJX01015",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": 14000,
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/asston-pharmaceu-10039662-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 6,
    "sid": "10039662",
    "stock_news_url": "https://www.marketsmojo.com/news/asston-pharmaceuticals-10039662"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Apr-2026",
      "details": "Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018",
      "source": "BSE"
    },
    {
      "caption": "Notice Of Extraordinary General Meeting",
      "datetime": "06-Apr-2026",
      "details": "Please find attached the Notice of Extraordinary General Meeting scheduled to be held on 28th April 2026",
      "source": "BSE"
    },
    {
      "caption": "Record Date",
      "datetime": "06-Apr-2026",
      "details": "Intimation of record date i.e. 17th April 2026 for the E-voting process pursuant to the Extraordinary General Meeting scheduled to be held on 28th April 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News